Avenue Therapeutics, Inc. · OTC:ATXI

Fortress Biotech, Inc. reported a 10.30% stake in Avenue Therapeutics, Inc. (Schedule 13D/A)

Event Mar 31, 2025 · Filed Apr 2, 2025

Fortress Biotech, Inc. reported a 10.30% stake in Avenue Therapeutics, Inc., 328,746 shares, with active intent on Mar 31, 2025. Filed Apr 2, 2025 (Schedule 13D/A).

Stake
10.30%
Shares
328,746
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
Fortress Biotech, Inc.10.30%328,746

Source

View original at SEC

Related